Corcept Therapeutics, Inc. (CORT)
58.14
+1.06
(+1.86%)
USD |
NASDAQ |
May 14, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly) : 176.89M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 82.75B |
| Supernus Pharmaceuticals, Inc. | 423.92M |
| Terns Pharmaceuticals, Inc. | 18.73M |
| Nektar Therapeutics | 187.06M |
| Pacira Biosciences, Inc. | 554.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 814.88M |
| Shareholders Equity (Quarterly) | 637.99M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 2.826 |
| Net Debt Paydown Yield | -0.01% |